Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH
NCT02734953
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
Nitric Oxide
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)